Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

Pfizer’s Xeljanz becomes first JAK inhibitor approved in US for active ulcerative colitis

May 31, 2018 Sales and Marketing FDA, Pfizer, US, Xeljanz, pharma, ulcerative colitis

Pfizer has revealed that its Janus kinase (JAK) inhibitor Xeljanz (tofacitinib) has received FDA approval for the treatment of adult …
News
pharmafocus_june_2018_cover

The June 2018 issue of Pharmafocus is now live!

May 31, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Ebola, GDPR, Trump, UK, brexit, data managment, market access, pharma

The new June edition of Pharmafocus is now available to read online.
News
fda_building_web

FDA approval for TherapeuticsMD, one year after initial rejection

May 30, 2018 Sales and Marketing FDA, TherapeuticsMD, biotech, drugs, pharma, pharmaceutical

TherapeuticsMD has succeeded in changing the FDA’s mind on its Imvexxy product, after an initial rejection in May of last …
News

Insider Interview: Gilead’s fight against HIV comes into bloom

May 30, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, HIV, Insider Interview, pharma

Mike Elliott, Vice President of Medical Affairs at Gilead (pictured, right), chats about the company’s sponsorship of a ‘A life …
Feature

Envision Pharma Group supports Otsuka’s medical affairs activities

May 30, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Envision Pharma Group

Envision Pharma Group announces the successful implementation of iEnvision to connect and support Otsuka’s medical affairs activities. Otsuka Pharmaceutical Development …
News
Press release
ema_building_face_web

AB Science will not seek review of masitinib rejection in Europe

May 29, 2018 Manufacturing and Production, Sales and Marketing EMA, Europe, ab science, als, masitinib, pharma

AB Science has U-turned on its pursuit of a do-over on its marketing application of masitinib in Europe after the …
News

UCB’s Cimzia secures first-of-its-kind FDA approval in plaque psoriasis

May 29, 2018 Manufacturing and Production, Sales and Marketing Cimzia, FDA, UCB, US, pharma, psoriasis

The FDA has expanded the label for UCB’s Cimzia (certolizumab pegol) in the US, approving the therapy for the treatment …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

May 25, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Cancer, Gielad, Novartis, brexit, obesity, pharma, top ten

It’s a special Firday here in Europe, as today marks the advent of the General Data Protection Regulation (GDPR), an …
News
novato-south-campus

BioMarin receives FDA nod for its would-be blockbuster

May 25, 2018 Medical Communications, Sales and Marketing BioMarin, biotech, drugs, pharma, pharmaceutical

BioMarin is confident that its newly approved treatment for phenylketonuria (PKU) is set to become a blockbuster and it’s priced the …
News
teething__daniel_schwen

FDA cracks down on benzocaine teething products

May 24, 2018 Sales and Marketing FDA, benzocaine, pharma, teething products

The FDA has put its foot down on over-the-counter teething products for infants and children which contain benzocaine, a pain …
News
john_crowley_edit

John Crowley speaks on drug development and the FDA

May 24, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amicus Therapeutics, John Crowley, biotech, drugs, pharma, pharmaceutical

Pharmafocus spoke to John Crowley, CEO of Amicus Therapeutics, about his highly unusual career in the pharmaceutical and biotech industries.
Feature
novartis_outside_1

Novartis’ Sandoz scores EU approval for Remicade biosimilar

May 24, 2018 Sales and Marketing EU, Europe, Novartis, Remicade, Sandoz, Zessly, pharma

The European Commission has given its approval to Sandoz, Novartis’ generics and biosimilars unit, for its biosimilar version of Janssen’s …
News
merck_and_co

MSD’s Keytruda scores impressive first-line lung cancer data

May 24, 2018 Research and Development, Sales and Marketing MSD, biotech, drugs, keytruda, pharma, pharmaceutical

MSD Keytruda has enjoyed the most success of the PD-1/L1 therapies in clinical trials recently and it’s rapidly cementing its …
News
handshake_2

Vifor Fresenius snap up rights to Cara’s itch therapy

May 23, 2018 Research and Development, Sales and Marketing Cara Therapeutics, Vifor Fresenius, biotech, drugs, pharma, pharmaceutical

The joint partnership between Vifor Pharma and Fresenius Medical Care, Vifor Fresenius, has put down $50 in upfront cash and …
News
fda2outsideweb

Sun Pharma drug combo scores FDA approval in advanced castration-resistant prostate cancer

May 23, 2018 Research and Development, Sales and Marketing Cancer, Churchill Pharmaceuticals, FDA, Sun Pharma, US, Yonsa, pharma, prostate cancer

Sun Pharma is celebrating with the announcement that its CYP17 inhibitor Yonsa (abiraterone acetate) has been awarded FDA approval in …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025